Status:
COMPLETED
Safety and Efficacy of MCG for Diagnosing Coronary Heart Disease
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
CardioMag Imaging
Conditions:
Myocardial Ischemia
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
A magnetocardiograph (MCG) is a medical device capable of recording the magnetic fields that arise from the electrical activity of the heart. It was developed for the general purpose as a noninvasive,...
Detailed Description
The CMI-2409 magnetocardiograph (MCG) is an FDA-approved medical device capable of noninvasive recording of magnetic fields arising from the electrical activity of the heart. This system was developed...
Eligibility Criteria
Inclusion
- Subjects with chest pain syndrome or angina equivalent
Exclusion
Key Trial Info
Start Date :
July 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2007
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT00170027
Start Date
July 1 2003
End Date
July 1 2007
Last Update
February 15 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905